Results 111 to 120 of about 15,844 (277)
Hypocalcaemia as an important differential diagnosis in patients suffering from stridor following thyroidectomy [PDF]
Christine Nitschke +3 more
openalex +1 more source
Abstract A 6.5‐year‐old, spayed, female dog presented in acute respiratory distress. On admission, the dog exhibited dyspnoea, bradycardia, cyanosis and gastrointestinal signs, requiring immediate intubation and mechanical ventilation. Diagnostic evaluation revealed reduced butyrylcholinesterase activity, non‐cardiogenic pulmonary oedema, elevated ...
Sarah Hefer +6 more
wiley +1 more source
Severe increase in creatinine with hypocalcaemia in thalidomide‐treated myeloma patients receiving zoledronic acid infusions [PDF]
Stephen G. Jones +3 more
openalex +1 more source
Severe anaemia secondary to duodenal adenoma in a cat
Abstract A 7‐year‐old female, spayed, domestic shorthair presented with a 24‐hour history of anorexia, lethargy and melaena. The cat was hospitalized and received treatment for hypovolemia, various electrolyte abnormalities and severe anaemia with a blood transfusion, intravenous fluids and medications.
Jocosa Yasenchack +4 more
wiley +1 more source
The KYUCOG‐1901 prospective multicenter study evaluated radium‐223 in 93 Japanese patients with bone‐metastatic castration‐resistant prostate cancer. Ra‐223 was well tolerated, produced meaningful declines in ALP, and yielded a median overall survival of 23.0 months. Early initiation in patients with lower disease burden and integration with subsequent
Masaki Shiota +12 more
wiley +1 more source
The physiology of survival: Breath‐hold shallow‐water diving
Experimental Physiology, EarlyView.
Andrew H. Baker +8 more
wiley +1 more source
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami +2 more
wiley +1 more source
ABSTRACT Relapsed/refractory (R/R) mantle cell lymphoma (MCL) remains a therapeutic challenge, particularly in patients with high‐risk features or prior exposure to Bruton's tyrosine kinase inhibitors (BTKis). The advent of T‐cell–redirecting immunotherapies, including chimeric antigen receptor T‐cell (CAR‐T) therapy and bispecific antibodies (BsAbs ...
Santino Caserta +10 more
wiley +1 more source

